STATE STREET CORP - ARCUTIS BIOTHERAPEUTICS INC ownership

ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 109 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of ARCUTIS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$23,155,885
-53.5%
4,360,807
-16.6%
0.00%
-66.7%
Q2 2023$49,803,866
+25.3%
5,226,009
+44.6%
0.00%
+50.0%
Q1 2023$39,762,591
-63.5%
3,614,781
-50.9%
0.00%
-33.3%
Q4 2022$108,909,796
+114.6%
7,358,770
+177.1%
0.00%0.0%
Q3 2022$50,742,000
+70.5%
2,655,235
+90.1%
0.00%
+50.0%
Q2 2022$29,758,000
+29.9%
1,396,425
+17.4%
0.00%
+100.0%
Q1 2022$22,910,000
-1.4%
1,189,500
+6.2%
0.00%0.0%
Q4 2021$23,235,000
-6.4%
1,120,306
+7.8%
0.00%0.0%
Q3 2021$24,827,000
-21.1%
1,039,213
-9.8%
0.00%
-50.0%
Q2 2021$31,451,000
+12.3%
1,152,482
+19.1%
0.00%0.0%
Q1 2021$28,004,000
+18.7%
967,982
+15.4%
0.00%
+100.0%
Q4 2020$23,602,000
+203.5%
839,022
+216.1%
0.00%0.0%
Q3 2020$7,777,000
+37.8%
265,434
+42.3%
0.00%
Q2 2020$5,642,000
+13.0%
186,580
+11.4%
0.00%
Q1 2020$4,993,000167,5580.00%
Other shareholders
ARCUTIS BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Frazier Life Sciences Management, L.P. 8,684,232$46,113,2723.06%
Pivotal bioVenture Partners Investment Advisor LLC 1,105,309$5,869,1912.34%
Bain Capital Life Sciences Investors, LLC 3,000,000$15,930,0001.78%
Sio Capital Management, LLC 635,969$3,376,9951.04%
Rubric Capital Management LP 5,034,530$26,733,3541.00%
Tejara Capital Ltd 309,179$1,641,7400.93%
AlphaCentric Advisors LLC 165,000$876,1500.50%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,135,227$6,028,0550.33%
Orbimed Advisors 1,914,479$10,165,8830.22%
Two Seas Capital LP 164,807$875,1250.18%
View complete list of ARCUTIS BIOTHERAPEUTICS INC shareholders